NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Speech in Noise Discrimination Skills in Multiple Sclerosis Patients.

CompletedNA

Sponsor: Asuman Kucukoner

Conditions: Multiple Sclerosis-Relapsing-Remitting

Interventions: Hearing test, Speech in noise discrimination test, Montreal Cognitive Assessment Scale, Symbol Number Modalities Test (SDMT)

Countries: Turkey (Türkiye)

The aim of this clinical trial was to determine the effect of multiple sclerosis on speech reception and discrimination in noise and to compare the effects on the medial olivocochlear reflex, which is thought to affect speech intelligibility in noise, with a control group. The main questions it aims to answer are: Does MS disease affect the ability to discriminate speech in noise? Does MS affect contralateral suppression results assessing medial olivocochlear function? Is there a correlation between the ability to discriminate speech in noise and contralateral suppression skills of MS patients? Data from MS patients and healthy participants will be compared. Thirty relapsing remitting MS patients and 30 healthy participants admitted to the clinic will be evaluated.

Eligibility overview

Sex: ALL

Age: 18 Years to 50 Years

Healthy volunteers: Yes

Study type: INTERVENTIONAL

Eligibility criteria

Inclusion Criteria:

Clinical diagnosis of Relapsing-remitting MS The absence of other neurological, psychiatric or metabolic diseases besides MS.

Exclusion Criteria:

Exclusion criteria for this group included patients with exacerbation and/or steroid treatment in the last three months, as well as those with a history smoking, alcohol or sedative drug use, unstable vital signs, pregnancy, and serious health problems such as heart or kidney failure, major depression, severe anemia, immunodeficiency, narcolepsy, etc.

Locations (1)

Samsun, Turkey (Türkiye)